December 18, 2024

Major Heart Failure Trial Yields Key Data

A recent multicenter trial investigated the impact of potassium nitrate supplementation on exercise capacity and quality of life in patients with heart failure with preserved ejection fraction, revealing interesting insights into blood nitric oxide metabolites.

Conexiant

December 18, 2024

FDA Flags Serious Risk in Catheter Recall

The FDA has issued a 'most serious' classification for the recall of Boston Scientific's catheters used in minimally invasive surgery, linked to reports of esophageal injury and fatalities.

Reuters

December 16, 2024

New Four-Stage System Redefines AF Care

New atrial fibrillation management guidelines embrace a novel 4-stage classification system and early rhythm control strategy, with clinical trials showing a 21% reduction in cardiovascular outcomes when rhythm control is initiated within 12 months of diagnosis.

Conexiant

December 13, 2024

New Myocarditis Guidelines Define Disease Stages

ACC consensus pathway introduces stages A through D for myocarditis classification, paralleling the established heart failure staging system cardiologists use daily.

Conexiant

December 13, 2024

Air Pollution Tied to Blood Clots in Veins

In a 17-year study of over 6,600 adults, researchers found that for every 3.6 µg/m3 increase in PM2.5 exposure, VTE risk increased by 39%, with even stronger associations observed in the first decade of follow-up.

Conexiant

December 12, 2024

Comparing Ticagrelor and Prasugrel in ACS

In a 17,642-patient cohort study validating ISAR-REACT5's findings, prasugrel showed particular benefit in STEMI patients, with a striking 38% relative risk reduction in adverse events compared to ticagrelor, while maintaining similar bleeding risks.

Conexiant

December 09, 2024

CLEAR Trial: Evaluating Spironolactone in Post-MI Care

A recent study evaluated the routine use of spironolactone in patients with myocardial infarction to assess its effect on cardiovascular outcomes.

Conexiant

December 05, 2024

AHA: Smokeless Nicotine's CVD Risks

New data reveals smokeless oral nicotine products show lower cardiovascular risks than cigarettes but are associated with increased mortality in patients with existing heart conditions.

Conexiant

November 27, 2024

Can Better AF Ablation Boost Success Rates?

Study unveils promising findings in the PROMPT-AF trial, where linear ablation with ethanol infusion via the vein of Marshall achieved 70.7% freedom from atrial arrhythmias at 12 months compared to 61.5% with pulmonary vein isolation alone.

Conexiant